Spots Global Cancer Trial Database for A Phase II Study of AS1411 in Renal Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase II Study of AS1411 in Renal Cell Carcinoma
Official Title: A Phase II, Open Label, Single Arm Study of AS1411 in Patients With Metastatic Renal Cell Carcinoma
Study ID: NCT00740441
Conditions
Interventions
Study Description
Brief Summary: The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope, Duarte, California, United States
University of California, Davis Cancer Center, Sacramento, California, United States
University of California San Francisco, San Francisco, California, United States
St Francis Hospital, Beech Grove, Indiana, United States
James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Contact Details
Name: Greg Smith, MD
Affiliation: Saint Francis Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Harry Drabkin, MD
Affiliation: Medical University of South Carolina
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
